Tagged:
Surrogate end point
A surrogate endpoint, in the context of a clinical trial, refers to an outcome that offers indirect evidence of another desired clinical outcome. (For example, reduction in blood pressure can be a surrogate end point evidencing reduction in the risk of having a stroke.)